Orexo Future Growth

Future criteria checks 4/6

Orexo is forecast to grow earnings and revenue by 71.8% and 11.3% per annum respectively while EPS is expected to grow by 71.8% per annum.

Key information

71.8%

Earnings growth rate

71.8%

EPS growth rate

Pharmaceuticals earnings growth19.3%
Revenue growth rate11.3%
Future return on equityn/a
Analyst coverage

Low

Last updated25 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0H19 - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026686-2058631
12/31/2025583-79-4N/A1
12/31/2024584-120-37-321
9/30/2024596-105-46-41N/A
6/30/2024615-97-61-50N/A
3/31/2024619-73-72-52N/A
12/31/2023639-128-114-95N/A
9/30/2023629-201-172-141N/A
6/30/2023634-195-205-180N/A
3/31/2023624-218-176-157N/A
12/31/2022624-178-180-157N/A
9/30/2022612-152-203-188N/A
6/30/2022597-177-241-207N/A
3/31/2022592-216-285-243N/A
12/31/2021565-223-282-229N/A
9/30/2021580-207-239-160N/A
6/30/2021585-240-201-93N/A
3/31/2021621-198-281-79N/A
12/31/2020664-84-17317N/A
9/30/20207434-9484N/A
6/30/202082420189231N/A
3/31/2020846288248284N/A
12/31/2019845219255287N/A
9/30/2019834232286302N/A
6/30/2019819182192194N/A
3/31/2019818178183187N/A
12/31/2018783138238242N/A
9/30/2018747113144147N/A
6/30/201869779N/A215N/A
3/31/201865632N/A225N/A
12/31/201764423N/A147N/A
9/30/201763719N/A241N/A
6/30/201765327N/A191N/A
3/31/201768229N/A151N/A
12/31/201670629N/A156N/A
9/30/2016752-57N/A84N/A
6/30/2016710-139N/A-38N/A
3/31/2016648-229N/A-82N/A
12/31/2015646-210N/A-109N/A
9/30/2015636-95N/A-116N/A
6/30/2015627-85N/A-188N/A
3/31/2015617-51N/A-381N/A
12/31/2014570-57N/A-487N/A
9/30/2014449-146N/A-593N/A
6/30/2014440-138N/A-671N/A
3/31/2014391-204N/A-358N/A
12/31/2013429-155N/A-263N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0H19 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).

Earnings vs Market: 0H19 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 0H19 is expected to become profitable in the next 3 years.

Revenue vs Market: 0H19's revenue (11.3% per year) is forecast to grow faster than the UK market (3.5% per year).

High Growth Revenue: 0H19's revenue (11.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 0H19's Return on Equity is forecast to be high in 3 years time


Discover growth companies